These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. A rational approach to the treatment of vitiligo and other hypomelanoses. Hercogová J; Buggiani G; Prignano F; Lotti T Dermatol Clin; 2007 Jul; 25(3):383-92, ix. PubMed ID: 17662904 [TBL] [Abstract][Full Text] [Related]
11. [Skin implants in vitiligo]. Machado Filho CD; Bouro Neto JB Med Cutan Ibero Lat Am; 1985; 13(3):243-6. PubMed ID: 3906316 [TBL] [Abstract][Full Text] [Related]
14. Experience with calcipotriol as adjunctive treatment for vitiligo in patients who do not respond to PUVA alone: a preliminary study. Yalçin B; Sahin S; Bükülmez G; Karaduman A; Atakan N; Akan T; Kölemen F J Am Acad Dermatol; 2001 Apr; 44(4):634-7. PubMed ID: 11260538 [TBL] [Abstract][Full Text] [Related]
15. Vitix--a new treatment for vitiligo? Schallreuter KU; Rokos H Int J Dermatol; 2005 Nov; 44(11):969-70. PubMed ID: 16336538 [No Abstract] [Full Text] [Related]
16. Vitiligo: an update on current pharmacotherapy and future directions. Colucci R; Lotti T; Moretti S Expert Opin Pharmacother; 2012 Sep; 13(13):1885-99. PubMed ID: 22835073 [TBL] [Abstract][Full Text] [Related]